Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Showing results (31-40 of 241) with videos related to

Pageof 25
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cellsDavid Franco, Weimin Liu, David F Gardiner, et al.
Nature Biotechnology|October 8, 2013
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activityRuijiang Song, Deena A Oren, David Franco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2008
Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B'Zhiwei Chen, Yaoxing Huang, Xiuqing Zhao, et al.
Journal of Virology|May 14, 2010
Epitope mapping of ibalizumab, a humanized anti-CD4 monoclonal antibody with anti-HIV-1 activity in infected patientsRuijiang Song, David Franco, Chia-Ying Kao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaquesHannah Yuan Chen, Michele Di Mascio, Alan S Perelson, et al.
Journal of Molecular Cell Biology|December 1, 2021
Comments on 'An airway organoid-based screen identifies a role for the HIF1α‒glycolysis axis in SARS-CoV-2 infection'Xiaohua Duan, Hui Wang, David D Ho, et al.
Mathematical Biosciences|February 10, 2004
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapyMichele Di Mascio, Ruy M Ribeiro, Martin Markowitz, et al.
The Journal of Infectious Diseases|July 25, 2009
A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feedingKe Liang, Xien Gui, Yuan-Zhen Zhang, et al.
Plos Pathogens|October 5, 2005
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversificationViviana Simon, Veronique Zennou, Deya Murray, et al.
Frontiers in Immunology|June 5, 2023
An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody designZizhang Sheng, Jude S Bimela, Maple Wang, et al.
Pageof 25

Showing results (31-40 of 241) with videos related to

Sort By:
Pageof 25
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cellsDavid Franco, Weimin Liu, David F Gardiner, et al.
Nature Biotechnology|October 8, 2013
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activityRuijiang Song, Deena A Oren, David Franco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2008
Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B'Zhiwei Chen, Yaoxing Huang, Xiuqing Zhao, et al.
Journal of Virology|May 14, 2010
Epitope mapping of ibalizumab, a humanized anti-CD4 monoclonal antibody with anti-HIV-1 activity in infected patientsRuijiang Song, David Franco, Chia-Ying Kao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaquesHannah Yuan Chen, Michele Di Mascio, Alan S Perelson, et al.
Journal of Molecular Cell Biology|December 1, 2021
Comments on 'An airway organoid-based screen identifies a role for the HIF1α‒glycolysis axis in SARS-CoV-2 infection'Xiaohua Duan, Hui Wang, David D Ho, et al.
Mathematical Biosciences|February 10, 2004
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapyMichele Di Mascio, Ruy M Ribeiro, Martin Markowitz, et al.
The Journal of Infectious Diseases|July 25, 2009
A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feedingKe Liang, Xien Gui, Yuan-Zhen Zhang, et al.
Plos Pathogens|October 5, 2005
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversificationViviana Simon, Veronique Zennou, Deya Murray, et al.
Frontiers in Immunology|June 5, 2023
An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody designZizhang Sheng, Jude S Bimela, Maple Wang, et al.
Pageof 25